Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15541087rdf:typepubmed:Citationlld:pubmed
pubmed-article:15541087lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15541087lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:15541087lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:15541087lifeskim:mentionsumls-concept:C0036508lld:lifeskim
pubmed-article:15541087lifeskim:mentionsumls-concept:C0005309lld:lifeskim
pubmed-article:15541087lifeskim:mentionsumls-concept:C1099414lld:lifeskim
pubmed-article:15541087lifeskim:mentionsumls-concept:C1378128lld:lifeskim
pubmed-article:15541087pubmed:issue5lld:pubmed
pubmed-article:15541087pubmed:dateCreated2004-11-15lld:pubmed
pubmed-article:15541087pubmed:abstractTextSeborrhoeic dermatitis is a chronic inflammatory disease with remissions and exacerbations, characterized by erythema, scaling and pruritus primarily on the face, scalp and chest. Corticosteroids and antifungals are the mainstay of therapy. However, chronic use of corticosteroids is associated with side-effects such as skin atrophy and telangiectasia. Pimecrolimus, an inhibitor of calcineurin, has been used successfully in one patient with seborrhoeic dermatitis.lld:pubmed
pubmed-article:15541087pubmed:languageenglld:pubmed
pubmed-article:15541087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15541087pubmed:citationSubsetIMlld:pubmed
pubmed-article:15541087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15541087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15541087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15541087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15541087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15541087pubmed:statusMEDLINElld:pubmed
pubmed-article:15541087pubmed:monthNovlld:pubmed
pubmed-article:15541087pubmed:issn0007-0963lld:pubmed
pubmed-article:15541087pubmed:authorpubmed-author:KatsambasAAlld:pubmed
pubmed-article:15541087pubmed:authorpubmed-author:Kalogeromitro...lld:pubmed
pubmed-article:15541087pubmed:authorpubmed-author:RigopoulosDDlld:pubmed
pubmed-article:15541087pubmed:authorpubmed-author:IoannidesDDlld:pubmed
pubmed-article:15541087pubmed:authorpubmed-author:GregoriouSSlld:pubmed
pubmed-article:15541087pubmed:issnTypePrintlld:pubmed
pubmed-article:15541087pubmed:volume151lld:pubmed
pubmed-article:15541087pubmed:ownerNLMlld:pubmed
pubmed-article:15541087pubmed:authorsCompleteYlld:pubmed
pubmed-article:15541087pubmed:pagination1071-5lld:pubmed
pubmed-article:15541087pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:meshHeadingpubmed-meshheading:15541087...lld:pubmed
pubmed-article:15541087pubmed:year2004lld:pubmed
pubmed-article:15541087pubmed:articleTitlePimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.lld:pubmed
pubmed-article:15541087pubmed:affiliationNational University of Athens Medical School, A. Syrgos Hospital, Athens, Greece. drigop@hol.grlld:pubmed
pubmed-article:15541087pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15541087pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15541087pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15541087pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15541087lld:pubmed